1 / 13

Molecular Diagnostics Market to exceed US$ 20 Billion by 2024

For more Info: <br><br>https://www.renub.com/molecular-diagnostics-market-nd.php<br><br>Molecular diagnostics is termed as to the detection of genomic variants, with the aim to facilitate physicians in the detection, prognosis, diagnosis, sub-classification and further monitoring response to the given therapy. Molecular diagnostics is the outcome of productive relationships between genomics knowledge, laboratory medicine and the use of improved technology in the field of molecular genetics. All these factors help in the better recognition and fine categorization of the genetic basis of inherited diseases which in turn, is essential for the accurate specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024.<br><br>Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS)<br>Over the last few decades, several molecular assays have been developed using a variety of technologies. Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the leading molecular diagnostics technologies, which is being used for the rapid diagnosis of various diseases. For instance: diagnosis of pulmonary tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high yield even in patients with sputum smear-negative pulmonary tuberculosis and is now being endorsed for routine use by WHO. High-end molecular diagnostic techniques such as next-generation sequencing (NGS) offer valuable insights into the mechanisms of disease while genomic biomarkers provide physician not only to evaluate the disease predilection but also to implement accurate diagnostic techniques and to individualize medicinal modalities. <br>

renubresearch
Download Presentation

Molecular Diagnostics Market to exceed US$ 20 Billion by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Diagnostics Market Report

  2. Global Molecular Diagnostics Market & Forecast Analyst View: • Global Molecular Diagnostics Market to exceed US$ 20 Billion by 2024. Get Free Customization in this Report • Press Release Title: • Molecular Diagnostics Market to exceed US$ 20 Billion by 2024 • For more Info:  • https://www.renub.com/molecular-diagnostics-market-nd.php

  3. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024. • Research Report Title: • Molecular Diagnostics Market, Global Forecast by Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others) • Access Full Research:  • https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php

  4. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024. Molecular diagnostics is termed as to the detection of genomic variants, with the aim to facilitate physicians in the detection, prognosis, diagnosis, sub-classification and further monitoring response to the given therapy. Molecular diagnostics is the outcome of productive relationships between genomics knowledge, laboratory medicine and the use of improved technology in the field of molecular genetics. All these factors help in the better recognition and fine categorization of the genetic basis of inherited diseases which in turn, is essential for the accurate specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024. Request a free sample copy of the report:  https://www.renub.com/contactus.php

  5. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024.

  6. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024. Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) Over the last few decades, several molecular assays have been developed using a variety of technologies. Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the leading molecular diagnostics technologies, which is being used for the rapid diagnosis of various diseases. For instance: diagnosis of pulmonary tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high yield even in patients with sputum smear-negative pulmonary tuberculosis and is now being endorsed for routine use by WHO. High-end molecular diagnostic techniques such as next-generation sequencing (NGS) offer valuable insights into the mechanisms of disease while genomic biomarkers provide physician not only to evaluate the disease predilection but also to implement accurate diagnostic techniques and to individualize medicinal modalities.

  7. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024. Molecular Diagnostics for Infectious Disease Over the last several years, the expansion and application of molecular diagnostic techniques has spurred a revolution in the field of disease diagnosis and monitoring, especially for infectious diseases. Microbial phenotypic characteristics, such as bacteriophage, protein and chromatographic profiles, as well as susceptibility testing and biotyping, are used wide openly in today’s everyday laboratories for identification and differentiation. Nucleic acid techniques, such as various methods for generating restriction fragment length polymorphisms, plasmid profiling, and the polymerase chain reaction (PCR), are making increasing incursion into clinical laboratories. A PCR-based system helps to detect the etiology of the disease straight from the clinical samples without the need for culture and have been significantly useful in the rapid detection of un-culturable or fastidious microbes. In addition; sequence analysis of amplified microbial DNA allows for better characterization and identification of the pathogen.

  8. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024. Further, molecular diagnostics have also paved the roads for the microbiologists who now searched for go for more rapid and efficient means of microbial identification. The identification and differentiation of microbes have basically relied on the microbial growth variables and their morphology. Advancement in the molecular diagnostics has opened new possibilities for microbial identification and characterization. Client can Purchase this Report in Sections from below link:  Access full Research:  https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php Molecular Diagnostics Market is exploding very rapidly in the past few years as it has proven readily versatile for use in the clinical laboratory and promise to be exceptionally useful in the diagnosis, therapy, and epidemiologic investigations of various diseases and their control; it is believed that the molecular diagnostics market will keep flourishing in the coming years. Also, rapid detection and tests accuracy are believed to drive demand for molecular diagnostic tests for infectious disease. 

  9. Table of Contents for Global Molecular Diagnostics Market Key Topics Covered 1.    Executive Summary 2.    Global Molecular Diagnostic Market 3.    Market Share – Global Molecular Diagnostics 3.1    By Application 3.2    By Technology3.3    By Countries 3.4    By Companies 4.    Application – Molecular Diagnostics Market 4.1    Infectious Diseases 4.2    Blood Screening 4.3    Oncology / Cancer 4.4    Genetic Testing4.5    HLA (Tissue Typing) 4.6    Microbiology4.7    Cardiovascular Diseases 4.8    Neurological Diseases4.9    Pharmacogenomics 4.10    Others

  10. Table of Contents for Global Molecular Diagnostics Market 5.    Technology – Molecular Diagnostics Market 5.1    PCR 5.2    Transcription-Mediated Amplification 5.3    Hybridiazation 5.4    DNA Sequencing & NGS5.5    Microarray 5.6    Others 6.    Region - Molecular Diagnostics Market 6.1    United States 6.2    Europe6.3    India 6.4    China6.5    Japan 6.6    Brazil6.7    South Korea 6.8    Mexico6.9    Russia 6.10    Rest of World (ROW) 7.    End Users - Molecular Diagnostics Market 7.1    Hospitals & Academic Laboratories 7.2    Clinics and Commercial Laboratories7.3    Others

  11. Table of Contents for Global Molecular Diagnostics Market 8.    Roche Diagnostics – Company Analysis 8.1    Merger & Acquisitions 8.2    Sales Analysis 9.    Abbott Laboratories – Company Analysis 9.1    Merger & Acquisitions 9.2    Sales Analysis 10.    Myriad Genetics – Company Analysis 10.1    Merger & Acquisitions 10.2    Sales Analysis 11.    Qiagen – Company Analysis 11.1    Merger & Acquisitions 11.2    Sales Analysis 12.    BioMérieux’s Inc – Company Analysis 12.1    Merger & Acquisitions 12.2    Sales Analysis

  12. Table of Contents for Global Molecular Diagnostics Market 13.    Market Drivers 13.1    Various Developments in the Molecular Diagnostics Landscape13.2    Integral to Traditional Labs13.3    Improved Assay / Test Efficiencies13.4    Targeting Antibiotic Resistance13.5    Next Generation Ultrasensitive Molecular Diagnostics13.6    Increasing Investment in Genomics & Proteomics Research13.7    Technological Advances in Molecular Diagnostics13.8    Increasing Acceptance of the Personalized Medicine13.9    Growing Molecular Diagnostics for Food Safety 14.    Challenges 14.1    Dearth of Trained Professionals14.2    Regulatory Issues14.3    Various Factors Slowing Growth of Molecular Diagnostics14.4    Reimbursement Capabilities14.5    Quality Checkpoints, Awareness & Acceptance

  13. GetFree Customization in this Report • Diagnostics Market Reports: • https://www.renub.com/diagnostics-14-c.php

More Related